Blood Pressure Variability and Severity of Early Prognosis in Patients with Acute Pontine Infarction
Table 2
The common risk factors and therapies of 136 patients at admission.
Variables
PPI (n = 70)
DPI (n = 67)
value
Glucose
7.4 ± 0.4
6.3 ± 0.3
0.02
Glycated hemoglobin
7.0 ± 0.3
6.2 ± 0.2
0.01
LDL
2.7 ± 0.1
2.4 ± 0.1
0.03
HDL
1.1 ± 0.03
1.1 ± 0.03
0.3
Cholesterol
4.5 ± 0.1
4.3 ± 0.1
0.4
Triglyceride
1.4 ± 0.1
1.5 ± 0.1
0.5
Apolipoprotein A1
1.3 ± 0.03
1.3 ± 0.03
0.8
Apolipoprotein B
0.8 ± 0.02
0.9 ± 0.04
0.5
Lipoprotein
236.0 ± 31.3
197.5 ± 26.2
0.4
Creatinine
69.5 ± 2.1
71.0 ± 2.4
0.6
Urea
7.0 ± 1.0
6.7 ± 1.0
0.8
Uric acid
293.8 ± 10.5
325.4 ± 11.3
0.04
C-reactive protein
4.9 ± 2.5
3.5 ± 0.5
0.6
D-dimer
0.3 ± 0.02
0.3 ± 0.03
0.3
Fibrinogen
2.7 ± 0.1
2.7 ± 0.1
0.9
WBC
7.0 ± 0.2
7.3 ± 0.3
0.4
Non-HDL
3.3 ± 0.1
3.2 ± 0.1
0.5
Hemoglobin
140.4 ± 2.4
143.8 ± 1.8
0.3
Hcy
18.2 ± 2.5
21.6 ± 2.3
0.3
NIHSS score
4.9 ± 0.4
2.3 ± 0.3
<0.01
Thrombolytic therapy (n, %)
11 (15.7%)
7 (10.4%)
0.4
Acute antihypertensive treatment (n, %)
18 (25.7)
22 (32.8)
0.4
LDL, low-density lipoprotein; HDL, high-density lipoprotein; Hcy, homocysteine. Data are shown for the patients’ demographics. . NIHSS, National Institutes of Health Stroke Scale.
